Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04821622
Title Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Pfizer

prostate cancer

prostate adenocarcinoma



Enzalutamide + Talazoparib

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL

No variant requirements are available.